BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1303753)

  • 1. NMR analysis of regioselectivity in dephosphorylation of a triphosphotyrosyl dodecapeptide autophosphorylation site of the insulin receptor by a catalytic fragment of LAR phosphotyrosine phosphatase.
    Lee JP; Cho H; Bannwarth W; Kitas EA; Walsh CT
    Protein Sci; 1992 Oct; 1(10):1353-62. PubMed ID: 1303753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct functions of the two protein tyrosine phosphatase domains of LAR (leukocyte common antigen-related) on tyrosine dephosphorylation of insulin receptor.
    Tsujikawa K; Kawakami N; Uchino Y; Ichijo T; Furukawa T; Saito H; Yamamoto H
    Mol Endocrinol; 2001 Feb; 15(2):271-80. PubMed ID: 11158333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential dephosphorylation of a multiply phosphorylated insulin receptor peptide by protein tyrosine phosphatases.
    Ramachandran C; Aebersold R; Tonks NK; Pot DA
    Biochemistry; 1992 May; 31(17):4232-8. PubMed ID: 1373652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin receptor protein-tyrosine phosphatases. Leukocyte common antigen-related phosphatase rapidly deactivates the insulin receptor kinase by preferential dephosphorylation of the receptor regulatory domain.
    Hashimoto N; Feener EP; Zhang WR; Goldstein BJ
    J Biol Chem; 1992 Jul; 267(20):13811-4. PubMed ID: 1321126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dephosphorylation of insulin-receptor autophosphorylation sites by particulate and soluble phosphotyrosyl-protein phosphatases.
    King MJ; Sale GJ
    Biochem J; 1990 Feb; 266(1):251-9. PubMed ID: 1689998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
    Ahmad F; Goldstein BJ
    J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dephosphorylation of autophosphorylated insulin and epidermal-growth-factor receptors by two major subtypes of protein-tyrosine-phosphatase from human placenta.
    Tappia PS; Sharma RP; Sale GJ
    Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):69-74. PubMed ID: 1715686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protein tyrosine phosphatase LAR has a major impact on insulin receptor dephosphorylation.
    Mooney RA; Kulas DT; Bleyle LA; Novak JS
    Biochem Biophys Res Commun; 1997 Jun; 235(3):709-12. PubMed ID: 9207225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and expression of a unique receptor-like protein-tyrosine-phosphatase in the leucocyte-common-antigen-related phosphate family.
    Zhang WR; Hashimoto N; Ahmad F; Ding W; Goldstein BJ
    Biochem J; 1994 Aug; 302 ( Pt 1)(Pt 1):39-47. PubMed ID: 8068021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the activity of protein tyrosine phosphate 1C by its SH2 domains.
    Townley R; Shen SH; Banville D; Ramachandran C
    Biochemistry; 1993 Dec; 32(49):13414-8. PubMed ID: 7504950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of insulin signal transduction by eutopic overexpression of the receptor-type protein-tyrosine phosphatase LAR.
    Zhang WR; Li PM; Oswald MA; Goldstein BJ
    Mol Endocrinol; 1996 May; 10(5):575-84. PubMed ID: 8732688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin receptor and epidermal growth factor receptor dephosphorylation by three major rat liver protein-tyrosine phosphatases expressed in a recombinant bacterial system.
    Hashimoto N; Zhang WR; Goldstein BJ
    Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):569-76. PubMed ID: 1599438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific inhibition of insulin receptor dephosphorylation by a synthetic dodecapeptide containing sulfotyrosyl residues as phosphotyrosyl mimetic.
    Kole HK; Liotta AS; Garant MJ; Kole S; Bernier M
    Indian J Biochem Biophys; 1997; 34(1-2):50-5. PubMed ID: 9343928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the transmembrane protein tyrosine phosphatase lar by 3S-peptide-I enhances insulin receptor phosphorylation in intact cells.
    Kole HK; Kole S; Mallory BP; Li PM; Goldstein BJ; Bernier M
    J Basic Clin Physiol Pharmacol; 1998; 9(2-4):111-26. PubMed ID: 10212829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects.
    Ahmad F; Considine RV; Goldstein BJ
    J Clin Invest; 1995 Jun; 95(6):2806-12. PubMed ID: 7769120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate specificities of catalytic fragments of protein tyrosine phosphatases (HPTP beta, LAR, and CD45) toward phosphotyrosylpeptide substrates and thiophosphotyrosylated peptides as inhibitors.
    Cho H; Krishnaraj R; Itoh M; Kitas E; Bannwarth W; Saito H; Walsh CT
    Protein Sci; 1993 Jun; 2(6):977-84. PubMed ID: 8318901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two nonradioactive assays for phosphotyrosine phosphatases with activity toward the insulin receptor.
    Madden JA; Bird MI; Man Y; Raven T; Myles DD
    Anal Biochem; 1991 Dec; 199(2):210-5. PubMed ID: 1812786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Lck and Fyn tyrosine kinase activities by transmembrane protein tyrosine phosphatase leukocyte common antigen-related molecule.
    Tsujikawa K; Ichijo T; Moriyama K; Tadotsu N; Sakamoto K; Sakane N; Fukada S; Furukawa T; Saito H; Yamamoto H
    Mol Cancer Res; 2002 Dec; 1(2):155-63. PubMed ID: 12496362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knock-down of LAR protein tyrosine phosphatase induces insulin resistance.
    Mander A; Hodgkinson CP; Sale GJ
    FEBS Lett; 2005 Jun; 579(14):3024-8. PubMed ID: 15896785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-specific dephosphorylation and deactivation of the human insulin receptor tyrosine kinase by particulate and soluble phosphotyrosyl protein phosphatases.
    King MJ; Sharma RP; Sale GJ
    Biochem J; 1991 Apr; 275 ( Pt 2)(Pt 2):413-8. PubMed ID: 1850986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.